PHS
ARAY icon

PFM Health Sciences’s Accuray ARAY Stock Holding History

PFM Health Sciences’s Portfolio ARAY Stock Details ARAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,617,297
Closed -$7.71M – 89
2019
Q1 		$7.71M Sell
1,617,297
-1,129,339
-41% -$5.14M 0.17% 82
2018
Q4 		$9.37M Sell
2,746,636
-1,179,120
-30% -$4.78M 0.25% 74
2018
Q3 		$17.7M Sell
3,925,756
-1,124,814
-22% -$4.43M 0.26% 96
2018
Q2 		$20.7M Sell
5,050,570
-1,373,500
-21% -$6.36M 0.32% 89
2018
Q1 		$32.1M Buy
6,424,070
+2,047,492
+47% +$10.7M 0.65% 58
2017
Q4 		$18.8M Buy
4,376,578
+208,065
+5% +$955K 0.45% 65
2017
Q3 		$16.7M Sell
4,168,513
-647,821
-13% -$2.78M 0.33% 76
2017
Q2 		$22.9M Buy
4,816,334
+715,213
+17% +$3.14M 0.62% 51
2017
Q1 		$19.5M Buy
4,101,121
+907,566
+28% +$4.73M 0.49% 68
2016
Q4 		$14.7M Sell
3,193,555
-1,026,718
-24% -$5.33M 0.41% 68
2016
Q3 		$26.9M Sell
4,220,273
-1,560,420
-27% -$8.51M 0.79% 50
2016
Q2 		$30M Sell
5,780,693
-103,525
-2% -$566K 0.91% 46
2016
Q1 		$34M Buy
5,884,218
+760,070
+15% +$4.21M 1.05% 31
2015
Q4 		$34.6M Sell
5,124,148
-647,102
-11% -$4.16M 1.05% 36
2015
Q3 		$28.8M Buy
5,771,250
+1,342,989
+30% +$8.63M 0.81% 41
2015
Q2 		$29.8M Buy
4,428,261
+1,530,551
+53% +$11.4M 0.76% 46
2015
Q1 		$26.9M Buy
2,897,710
+2,063,425
+247% +$16.4M 0.74% 50
2014
Q4 		$6.3M Buy
+834,285
New +$5.88M 0.15% 83

Other funds holding ARAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PFM Health Sciences's ARAY Position: Q2 2019 in Review

PFM Health Sciences sold out of Accuray (ARAY) in Q2 2019, closing a stake of 1,617,297 shares — an estimated $7.71M sold.

PFM Health Sciences first reported a position in ARAY in Q4 2014 and held it in 18 quarters. The position peaked at $34.6M in Q4 2015. 127 funds tracked by Wall St. Rank hold ARAY as of Q2 2019.

  • PFM Health Sciences reported no remaining Accuray position as of Q2 2019 after selling out during the quarter.
  • PFM Health Sciences sold 1,617,297 Accuray shares in Q2 2019, an estimated $7.71M.
  • PFM Health Sciences first reported a position in Accuray in Q4 2014 and held it in 18 quarters.
  • PFM Health Sciences's Accuray position peaked at $34.6M in Q4 2015.
  • 127 funds tracked by Wall St. Rank held Accuray as of Q2 2019.

Based on PFM Health Sciences's 13F filing for Q2 2019, filed 14 Aug 2019.